Study investigating the impact of pharmacist involvement on the outcomes of diabetes medication therapy adherence program Malaysia

ABSTRACT

Involvement of pharmacists in improving medication adherence among diabetic patients is recognized globally. In Malaysian healthcare system, pharmacists are also operating health services i.e. Diabetes Medication Therapy Adherence Clinic [DMTAC]. This study aimed to assess the clinical outcomes of patients managed by pharmacists [DMTAC], in a Malaysian hospital setting. This was an open labelled randomised study. Type 2 diabetes patients with HbA1c >/=8% were recruited and arbitrarily divided into the intervention group [usual care plus DMTAC] and the non-intervention group [usual care only]. Those enrolled in the intervention group were scheduled for follow-up for eight consecutive visits. Improvements in lab results were compared longitudinally [pre and post analysis] between the groups. Data analysis was done using PASW 18[registered] version. A total of 76 patients were enrolled, with 39 patients in the intervention group and 37 patients in the non-intervention group. Mean HbA1c [-0.90% vs. -0.08%, p=0.011] and fasting blood glucose levels [-3.45mmol.l vs. +0.79mmol/l, p=0.002] reduced significantly between the intervention group vs. non-intervention group. Total cholesterol and low-density lipoprotein cholesterol [LDL-C] were also significantly reduced in the intervention group [TC -0.34mmol/l, p=0.018] [LDL -0.45mmol/l, p=0.001]. In conclusion, pharmacists managed DMTAC significantly improved glycaemic control and lipid profile of diabetic patients